21 results
DEFA14A
KDNY
Chinook Therapeutics Inc
26 Jul 23
Additional proxy soliciting materials
4:05pm
venture, in which it has a minority equity interest. Share-based compensation is treated as a cash expense.
(45)Reflects Unlevered Free Cash Flow
DEFM14A
KDNY
Chinook Therapeutics Inc
10 Jul 23
Proxy related to merger
4:01pm
Chinookâs share of the projected cash flows generated by its unconsolidated SanReno joint venture, in which it has a minority equity interest. Share
PREM14A
KDNY
Chinook Therapeutics Inc
27 Jun 23
Preliminary proxy related to merger
4:02pm
unconsolidated SanReno joint venture, in which it has a minority equity interest. Share-based compensation is treated as a cash expense.
Reflects Unlevered
8-K/A
EX-99.2
qrxhm8 oa7fesh
5 Nov 20
Index to Chinook Consolidated Financial Statements
4:58pm
424B3
p39 6rxzthqxb2g
26 Aug 20
Prospectus supplement
4:06pm
S-4/A
0wxzjtp
24 Aug 20
Registration of securities issued in business combination transactions (amended)
6:10am
S-4
w10wtff
22 Jul 20
Registration of securities issued in business combination transactions
12:00am
10-K
mg5jipiokwi
8 Mar 16
Annual report
12:00am
DRS/A
ye1 9yiol
28 Jan 15
Draft registration statement (amended)
12:00am